SCHEMBL34465701

SCHEMBL34465701

COCC(=O)N1[C@H](C)Cn2nc3c(F)c(Cl)c(N)cc3c2[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34466556 0.89 TSHR (0.30) —
SCHEMBL35212571 0.89 TSHR (0.31) —
SCHEMBL34466518 0.89 ALDH1A1 (0.30) —
SCHEMBL35211848 0.89 TSHR (0.31) —
SCHEMBL35212379 0.83 CCR1 (0.30) —
SCHEMBL35212427 0.83 CCR1 (0.30) —
SCHEMBL34465723 0.83 ALDH1A1 (0.31) —
SCHEMBL34465835 0.83 TSHR (0.30) —
SCHEMBL35212101 0.82 — —
SCHEMBL35212626 0.81 TSHR (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108509-A1 6-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-04-23 — — US disclosed
US-20260109704-A1 5-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-04-23 — — US disclosed
Send feedback